Boston Partners Teva Pharmaceutical Industries LTD Transaction History
Boston Partners
- $77.5 Billion
- Q2 2024
A detailed history of Boston Partners transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Boston Partners holds 56,280 shares of TEVA stock, worth $962,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,280
Previous 29,056
93.69%
Holding current value
$962,950
Previous $409,000
123.47%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TEVA
# of Institutions
624Shares Held
565MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$736 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$622 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$553 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$493 Million3.23% of portfolio
-
Exor Capital LLP London, X026.5MShares$453 Million15.49% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...